COMMUNIQUÉS West-GlobeNewswire

Sienna Announces July Dividend
15/07/2024
MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors
15/07/2024
SANTA ANA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
15/07/2024
Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN, South Korea and WALTHAM, Mass., July 15, 2024 ( [...]
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
15/07/2024
– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 [...]
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
15/07/2024
The company plans on operationalizing this new state-of-the-art facility in the first half of 2026 PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading [...]
CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications
15/07/2024
HOUSTON, July 15, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applications for crucial [...]
Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
15/07/2024
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2024 financial results on Monday, [...]
Spectral AI Continues Support of Naked Short Selling Inquiry
15/07/2024
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Teknova Announces Closing of $15.4 Million Private Placement
12/07/2024
HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/07/2024
SAN FRANCISCO, July 12, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
ARCPOINT ANNOUNCES PROPOSED SHARES FOR DEBT SETTLEMENT
12/07/2024
Greenville, South Carolina, July 12, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to announce that it has entered into a debt settlement agreement (the “ Agreement ”) [...]
HealthRecon Connect Successfully Achieves SOC 2 and SOC 3 Compliance
12/07/2024
DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- HealthRecon Connect, a leading technology enabled revenue cycle management solutions provider to US Healthcare Providers, reaffirmed its commitment to maintaining high standards [...]
MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department
12/07/2024
DALLAS, TEXAS, July 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products [...]
BioSenic S.A. : Transparency notification received from Véronique Pomi
12/07/2024
PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, July 12, 2024, 6pm CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical [...]
BioSenic S.A. : Notification de transparence reçue de la part de Véronique Pomi
12/07/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes Mont-Saint-Guibert, Belgique, le 12 juillet 2024 à 18h00 CEST – BIOSENIC (Euronext [...]
Clene to Present at the Emerging Growth Conference
12/07/2024
SALT LAKE CITY, July 12, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
AMN Healthcare to Hold Second Quarter 2024 Earnings Conference Call on Thursday, August 8, 2024
12/07/2024
DALLAS, July 12, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2024 financial results and third quarter 2024 outlook on Thursday, [...]
SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner
12/07/2024
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, [...]
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
12/07/2024
Vancouver, Canada, July 12, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Pages